Heart failure & cardiomyopathies

Setting the Optimal Threshold of NT-proBNP and BNP for the Diagnosis of Heart Failure in Patients Over 75 Years

ESC Heart FailPublished Retrospective cohort study

Authors' conclusion

In older patients, we found significant effects of co-morbidities on natriuretic peptides results, particularly in patients over 85 years old, older patients with abnormal renal function, obesity, and atrial fibrillation. Despite the consideration of those co-morbid conditions, NT-proBNP and BNP level continue to demonstrate utility in the diagnosis of AHF in older patients.

Study context

Population
Hospitalised patients aged ≥75 years with acute dyspnoea and BNP or NT-proBNP measured within 48 h of admission, 10 Assistance Publique-Hôpitaux de Paris facilities, 2011–20227,946 (65.8%) with acute heart failure (AHF)
Participants
12,071 patients
Exposure
NT-proBNP vs BNP
Outcome
Diagnostic thresholds of BNP and NT-proBNP for AHF (ICD-10 discharge diagnosis)
Methodological detailslongitudinal, multicentre
  • Longitudinal
  • Multicentre

Main finding

As reported in the abstract

Optimal NT-proBNP threshold for AHF diagnosis
GroupValuePPV
NT-proBNPthreshold 1748 ng/L84%

NT-proBNP

Valuethreshold 1748 ng/L
PPV84%

Observational data: associations, not effects.

Further findings

OutcomeNT-proBNP
AHF diagnosis, patients aged over 85 years (subgroup)
Threshold2235 pg/mL
PPV84%
AHF diagnosis, patients with AF (subgroup)
Threshold2332 pg/mL
PPV90%
AHF diagnosis, patients with eGFR < 30 mL/min (subgroup)
Threshold3474 pg/mL
PPV90%

AHF diagnosis, male patients (subgroup)

Threshold
1800 pg/mL
PPV for AHF diagnosis
85%

AHF diagnosis, patients with obesity (subgroup)

Threshold
1375 pg/mL
PPV for AHF diagnosis
85%

Original publication

Setting the Optimal Threshold of NT-proBNP and BNP for the Diagnosis of Heart Failure in Patients Over 75 Years. ESC Heart Fail. Published 24 June 2024. doi:10.1002/ehf2.14894

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.